This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Registry of Irreversible Electroporation for the A...
Clinical trial

Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device

Read time: 1 mins
Last updated:26th Sep 2014

The aim of this registry is to assess the recurrence of prostate cancer at 1 and 5 years, as well as the change in functional outcomes (e.g. incontinence or erectile function) from baseline. Secondary objectives are to establish which indications lead to treatment with IRE Nanoknife® setting and safety assessment measured by number of complications and adverse events.

Category Value
Study start date 2014-09-26

View full details